NTSR1-TARGETED RADIOPHARMACEUTICALS AND DNA DAMAGE RESPONSE INHIBITOR COMBINATION THERAPY

Abstract: methods for treating or ameliorating cancer comprising administering to a mammal a ntsr-1 targeted radiopharmaceutical comprising a radionuclide chelated to a compound of formula i, and dna damage response inhibitors.

Inventor(s): John R. Forbes, Saleemulla Mahammad

CPC Classification: A61K51/0497 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250177581